The Angiocrine Factor Rspondin3 Is a Key Determinant of Liver Zonation  by Rocha, Ana Sofia et al.
ReportThe Angiocrine Factor Rspondin3 Is a Key
Determinant of Liver ZonationGraphical AbstractHighlightsd Rspo3 is specifically expressed in central vein endothelial
cells of the liver
d Rspo3 is required to maintain metabolic zonation of the liver
d Ectopic expression of Rspo1 is sufficient to convert
hepatocytes to a central fateRocha et al., 2015, Cell Reports 13, 1757–1764
December 1, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.10.049Authors
Ana Sofia Rocha, Valerie Vidal,
Marjolijn Mertz, Timothy J. Kendall,
Aurelie Charlet, Hitoshi Okamoto,
Andreas Schedl
Correspondence
rocha@unice.fr (A.S.R.),
andreas.schedl@unice.fr (A.S.)
In Brief
Liver zonation is crucial to permit the
execution of the various metabolic
functions of this organ. Rocha et al. show
that RSPO3 is specifically expressed
within endothelial cells of the central vein,
where it acts on neighboring hepatocytes
to establish and maintain liver zonation
throughout life.
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Liver zonation, the spatial separation of different
metabolic pathways along the liver sinusoids, is
fundamental for proper functioning of this organ,
and its disruption can lead to the development of
metabolic disorders such as hyperammonemia.
Metabolic zonation involves the induction of b-cate-
nin signaling around the central veins, but how this
patterned activity is established and maintained is
unclear. Here, we show that the signaling molecule
Rspondin3 is specifically expressed within the endo-
thelial compartment of the central vein. Conditional
deletion of Rspo3 in mice disrupts activation of cen-
tral fate, demonstrating its crucial role in determining
and maintaining b-catenin-dependent zonation.
Moreover, ectopic expression ofRspo1, a close fam-
ily member of Rspo3, induces the expression of
pericentral markers, demonstrating Rspondins to
be sufficient to imprint a more central fate. Thus,
Rspo3 is a key angiocrine factor that controls meta-
bolic zonation of liver hepatocytes.
INTRODUCTION
The liver is a central organ responsible for the metabolism of di-
etary compounds, regulation of blood glucose levels, bile syn-
thesis, and biotransformation of xenobiotics and endogenous
byproducts of metabolism. During development, the fetus is
able to rely on the metabolic activity of the maternal liver. In
the neonatal period, however, the liver needs to undergo several
changes until reaching full maturation at weaning (Grijalva and
Vakili, 2013). This includes specialization of groups of hepato-
cytes, a process involving the activation of specific enzymes
that allow effective execution of metabolic tasks.
The functional unit of the liver consists of the hepatic lobule,
which includes a central vein connected to four to six portal tri-
ads via the hepatic plates. Hepatocytes located within theseCell Refunctional units perform specific functions depending on their
location within the lobule. Three zones of hepatocytes can be
distinguished: hepatocytes located closest to the periportal triad
(zone 1) are exposed to blood with the highest oxygen and
nutrient concentration and perform the majority of the liver’s
metabolic functions, including glycogen synthesis, gluconeo-
genesis, protein synthesis, and lipid metabolism. The hepato-
cytes closest to the central veins are located in zone 3 and are
specialized for biotransformation reactions, glycolysis, and
urea synthesis. Hepatocytes in zone 2 display an intermediate
phenotype executing both periportal and pericentral functions
(Torre et al., 2010).
On the molecular level, liver zonation is governed by canonical
Wnt/b-catenin signaling. Its activity is highest around the central
vein, and nuclear b-catenin directly regulates the activation of
genes involved in glutamine synthesis and drug metabolism
(Benhamouche et al., 2006; Burke et al., 2009; Sekine et al.,
2006). Consistent with this role in regulating the central fate, acti-
vation or attenuation of b-catenin signaling causes expansion or
diminution of central markers, respectively. Although the role of
Wnt/b-catenin signaling is well established, the factors deter-
mining when and where this pathway is active are still elusive.
The Rspondin family of Wnt agonists has recently been
demonstrated to play a major role in determining the levels of
Wnt/b-catenin activity (Yoon and Lee, 2012). Upon binding to
its receptors, the LGRs, Rspondins prevent membrane clear-
ance of Wnt receptors thereby promoting Wnt signaling activity
(Clevers et al., 2014). This signaling module has recently at-
tracted a lot of attention due to its role in stem cell biology,
with a particular emphasis on LGR5, which has been shown to
label stem cells in various tissues, both under physiological
and pathological conditions (Clevers et al., 2014). The liver is
no exception, and Huch et al. recently demonstrated that
LGR5 labels a damage-activated stem cell population (Huch
et al., 2013). Interestingly, LGR5 was shown to be differentially
expressed between periportal and pericentral hepatocytes
(Braeuning et al., 2006). LGR5 mRNA was exclusively identified
in pericentral hepatocytes in accordance with the observed
Wnt/b-catenin signaling activity in adult livers. This observa-
tion led us to investigate whether Rspondins play a role inports 13, 1757–1764, December 1, 2015 ª2015 The Authors 1757
Figure 1. Rspo3 Is an Endothelial Marker
Displaying Liver Patterning
(A) Rspo3 in situ hybridization and immunolabeling
of keratin 18 (green) in E17.5 livers.Rspo3-positive
endothelial cells were restricted to the central vein,
as evidenced by the lack of a differentiating ductal
plate labeled by keratin 18 expression (middle
panel).
(B) Rspo3 positive cells (blue) are detected in the
central vein endothelium in P10 and 8-week-old
animals. FewRspo3+ cells can be found in the liver
sinusoids in the vicinity of central veins. The Rspo3
expression domain overlaps with that of zone 3
hepatocytes, as evidenced by glutamine synthe-
tase labeling (green). See also Figure S1.
(C) qPCR analysis demonstrating Rspo3, Wnt2,
and Wnt9b enrichment in CD31+ sorted endothe-
lial cells. *p < 0.05; **0.05 < p < 0.001, ***p < 0.001
(Student’s t test).
All scale bars represent 50 mm; error bars repre-
sent SD.determining Wnt/b-catenin signaling activity and therefore in
regulating liver metabolic zonation.
RESULTS
Rspo3 Is an Endothelial-Specific Marker Demonstrating
Lobular Zonation
Rspondin expression has previously been analyzed during
development, but no liver-specific expression has been reported
(Nam et al., 2007). Because liver zonation is established soon
after birth andmaintained through adulthood, we began by char-
acterizing their expression profile at later stages of liver develop-
ment, namely at embryonic day 17.5 (E17.5), at postnatal day 10
(P10) as a representative time point for the postnatal period, and
in adulthood (8 weeks of age). RT-PCR analysis demonstrated
that Rspo1 and Rspo3 were expressed while Rspo2 and
Rspo4 were undetectable (Figure S1A). Although Rspo1 was
easily detectable by RT-PCR, we failed to observe a specific
expression pattern by in situ hybridization (data not shown).
The lack of involvement of Rspo1 was further confirmed in
knockout animals that showed overall normal liver histology
and maintained the expression of zonation markers, such as1758 Cell Reports 13, 1757–1764, December 1, 2015 ª2015 The Authorsglutamine synthetase (GS) (Figures S1B
and S1C). Given these observations, we
focused our attention on Rspo3.
In situ hybridization for Rspo3 demon-
strated an exclusively endothelial-spe-
cific expression pattern as early as
E17.5. Interestingly, the signal seemed
to be restricted to the central vein,
whereas endothelial cells localized at
sites of ductal plate differentiation (identi-
fied by high expression of keratin 18) were
consistently negative for Rspo3 (Fig-
ure 1A). The central-vein-specific expres-
sion profile of Rspo3 was maintained in
the perinatal period and adulthood. Toconfirm that Rspo3 expression was indeed endothelial, we
used fluorescence-activated cell sorting (FACS) to sort CD31+
cells from adult livers and compared the expression profile be-
tween sorted cells and whole liver. We observed a dramatic
enrichment of Rspo3, as well as the Wnt ligands Wnt2 and
Wnt9b, in the endothelial compartment (Figure 1C). Hepatocytes
surrounding theRspo3-positive veins displayed a strong expres-
sion of GS, a bona fide Wnt/b-catenin target in hepatocytes
(Figure 1B).
Rspo3 Is Required for the Onset and Maintenance of
Metabolic Zonation
Metabolic zonation has been suggested to involve position-spe-
cific differentiation along the lobule that begins after birth and
becomes fully established soon thereafter (Torre et al., 2010).
The close association between the Rspo3 expression domain
and that of central vein hepatocyte identity suggested that
Rspo3 might be responsible for the functional patterning of
pericentral hepatocytes by driving Wnt/b-catenin signaling.
Rspo3 knockout mice die around E9.5 due to defects in placenta
development (Aoki et al., 2007; Kazanskaya et al., 2008), thus
precluding analysis at later time points. Therefore, to functionally
Figure 2. Rspo3 Is Required for the Onset of Metabolic Zonation
(A) Schematic representation of the genetic approach used to delete Rspo3. Red arrowheads indicate loxP sites.
(B) Tamoxifen induction protocol used to delete Rspo3 in the perinatal period.
(C) qPCR analysis demonstrating efficient Rspo3 deletion and an 80%–90% downregulation of the Wnt/b-catenin target genes Axin2 and LGR5.
(D) GS expression (red) is lost in pericentral hepatocytes following Rspo3 deletion. The endothelial Wnt ligands Wnt2 and Wnt9b remained unchanged. Portal
tracts can be identified by bile ducts labeled by Krt18 (green).
(E) qPCR analysis of additional Wnt/b-catenin target/zonated genes demonstrated downregulation of pericentral-restricted genes.
(F) E-cadherin immunostaining (green) demonstrating a shift in its expression gradient.
(G) Wnt/b-catenin-negative targets become strongly upregulated by Rspo3 deletion.
cv, central vein; pv, portal vein. *p < 0.05; **0.05 < p < 0.001, ***p < 0.001 (Student’s t test). All scale bars represent 100 mm; error bars represent SD. See also
Figure S2.evaluate an involvement of this gene in liver zonation, we gener-
ated cCAG-CreERT2: Rspo3fl/fl mice that permit an inducible,
ubiquitous deletion of Rspo3 at any given time point. We admin-
istered tamoxifen to females at E16.5 days of pregnancy to
abolish Rspo3 expression during late development and perinatal
stages (Figures 2A and 2B). Livers were analyzed at P10, a time
point where zonation in wild-type mice is fully established. qPCR
analysis confirmed efficient Rspo3 deletion (98% reduction;
p = 0,0002). Loss ofRspo3 had a profound impact onWnt/ b-cat-
enin signaling, as evidenced by the dramatic reduction of the ca-
nonical Wnt/b-catenin targets Axin2 (90% reduction, p = 0,0006)
and LGR5 (98% reduction, p = 0,0003) (Figure 2C). The expres-
sion of endothelial-specificWnt2 andWnt9bwas not affected byCell ReRspo3 deletion, indicating that the observed phenotype is not
due to the absence of theWnt source but ratherRspo3 itself (Fig-
ure 2C). Immunohistochemical analysis revealed a complete loss
of expression of the pericentral zonation marker GS, demon-
strating an absolute requirement for Rspo3 in establishing peri-
central gene expression (Figure 2D). Similarly, expression of
Oat and Cyp7a1, two other genes restricted to pericentral hepa-
tocytes (Braeuning et al., 2006), was dramatically reduced (Fig-
ure 2E). Moreover, the periportal genes Cyp2f2 and Hsd17
showed a dramatic upregulation, further confirming profound
defects in the establishment of liver zonation (Figure 2G). E-cad-
herin, a marker of adult periportal hepatocytes, was not yet fully
zonated in P10 wild-type livers and, as evidenced in Figure 2F,ports 13, 1757–1764, December 1, 2015 ª2015 The Authors 1759
Figure 3. Rspo3 Is Required for the Maintenance of Metabolic Zonation
(A) Schematic representation of the genetic approach used to delete Rspo3 in adulthood. Red arrowheads indicate loxP sites.
(B) Tamoxifen induction protocol used to delete Rspo3 in 8-week-old animals. Knockout (KO) livers were analyzed 2 days and 4 weeks after the final injection.
(C) qPCR analysis demonstrating partial Rspo3 deletion, absence of changes inWnt2 andWnt9b expression and a downregulation of the Wnt/b-catenin target
genes Axin2 and LGR5.
(D) GS is expressed in a rim of hepatocytes surrounding the central vein (green), which is lost in pericentral hepatocytes followingRspo3 deletion. Portal tracts can
be identified by bile ducts labeled with Krt18 (red).
(E) qPCR analysis of additional Wnt/b-catenin target/zonated genes demonstrated downregulation of pericentral-specific genes.
(F) E-cadherin immunostaining (green) demonstrating a shift in its expression gradient.
(G) Wnt/b-catenin-negative targets become strongly upregulated upon Rspo3 deletion.
cv, central vein. *p < 0.05; **0.05 < p < 0.001, ***p < 0.001 (Student’s t test). All scale bars represent 100 mm; error bars represent SD. See also Figure S2.Rspo3 deletion did not result in dramatic changes in its expres-
sion pattern. The molecular changes were not due to apoptosis
of pericentral hepatocytes or to altered liver growth (Figures S2A
and S2B).
Central-vein-specific expression ofRspo3 is found throughout
life. To address whether continuous signaling may be required
to maintain liver zonation, we induced Rspo3 deletion in
8-week-old animals (Figure 3A and 3B). qPCR analysis demon-
strated a 50% reduction in Rspo3 levels following tamoxifen
induction, indicating only partial deletion of the floxed allele.
Importantly, a similar downregulation of the Wnt/b-catenin
targets Axin2 and LGR5 was observed (Figure 3C). Rspo3
deletion had no impact on Wnt2 and Wnt9b expression (Fig-
ure 3C). GS immunostaining was progressively lost in pericen-
tral hepatocytes, and 4 weeks after tamoxifen induction, some1760 Cell Reports 13, 1757–1764, December 1, 2015 ª2015 The Autareas surrounding central veins were completely devoid of GS-
positive cells (Figure 3D). Interestingly endothelial RSPO3
seems to act at a very close range, as GS-positive cells were
observed side by side with negative cells. In situ hybridization
demonstrated the presence of both recombined and non-
recombined cells in the same vein (Figure S2E), an observation
that might account for the heterogenous GS staining pattern.
The absence of GS-positive cells was not due to apoptosis of
pericentral hepatocytes, as demonstrated by histological anal-
ysis (Figures S2C and S2D) and the lack of activation of
caspase-3 (data not shown). qPCR analysis confirmed the
decreased expression of other zonated genes such as Oat,
Cyp7a1, and Rdh9 (Figure 3E). The involvement of Rspo3 in
maintaining the metabolic functions of the liver was further evi-
denced by a decrease of the amount of direct (conjugated)hors
bilirubin, the conjugation of which is performed in pericentral
hepatocytes (Figure S2E).
In adult livers, E-cadherin expression is restricted to periportal
hepatocytes. Rspo3 deletion induced a progressive expansion of
the periportal field, as evidenced by a dramatic increase in the
number of hepatocyte layers displaying E-cadherin labeling.
Expression of other periportal genes such as Cyp2f2 and Hsd17
showed an equally dramatic upregulation (Figures 3F and 3G).
Theobservedphenotypemimics thechangespreviouslyobserved
in livers fromb-cateninKOmutants, thus confirming thatRSPO3 is
required for Wnt/b-catenin signaling during adulthood. Thus liver
metabolic zonation is driven by an angiocrine factor, RSPO3,
that determines Wnt/b-catenin-mediated gene expression.
Ectopic Expression of Rspo1 Is Sufficient to Induce
b-Catenin Signaling and Aberrant Metabolic Zonation
We next investigated whether Rspondins might be sufficient to
imprint a central fate on all hepatocytes. Both in vivo and
in vitro analyses have demonstrated RSPO1 and RSPO3 to be
functionally analogous in their activation of canonical b-catenin
signaling. Indeed, stimulation of the AML12 hepatocyte cell line
with recombinant RSPO1 and RSPO3 resulted in increased acti-
vation of the Wnt/b-catenin signaling pathway albeit with some-
what lower efficiency (Figure S3A).We therefore decided to use a
Rspo1 gain-of-function (GOF) allele (Rosa26 knockin) previously
developed in our group (Figure S3B).
To ectopically express Rspo1, we used an inducible Alb-
CreERT2 system that drives CRE recombinase expression
specifically within hepatocytes. 8-week-old Alb-CreERT2:
R26Rspo1/+ old animals were treated with tamoxifen and the livers
analyzed2and28daysafter the last injection (Figures4Aand4B).
Rspo1 inductionwas accompanied by adramatic upregulation of
Axin2 and LGR5, thus validating our hypothesis that RSPO1 is
able to induce Wnt/b-catenin when ectopically expressed in he-
patocytes (Figure 4C). Following Rspo1 activation, a transient
change in Wnt9b expression was observed that disappeared at
later time points (Figure 4C). Alb-CreERT2; R26Rspo1/+ double-
transgenicmiceshowedaslight increase in liver size (FigureS3C),
which might be caused by cellular hypertrophy or a slight in-
crease in proliferation. This, however, did not impact liver struc-
ture (Figure S3D). Analysis of GS distribution demonstrated an
expansion of the pericentral domain, which was progressively
extended to zone 2 of the liver acinus, demonstrating that
RSPO1 is sufficient to activate Wnt/b-catenin signaling and
therefore induce a progressive expansion of GS+ hepatocytes
(Figures 4D and 4E). Conversely, periportal gene expression
was strongly downregulated, and 1 month after tamoxifen injec-
tion, E-cadherin was absent from all hepatocytes. qPCR analysis
of additional pericentral andperiportal genes confirmed that zone
2 was functionally converted into zone 3 (Figures 4F and 4G).
These observations were further confirmed by the analysis of
Alb-CreERT2: R26Rspo1/+ livers induced at E16.5, in which we
also observed an expansion of the pericentral fate (Figure S4).
DISCUSSION
b-Catenin signaling is a central pathway in liver biology that
serves equally important functions during development, tissueCell Rehomeostasis, and disease (Monga, 2014). Its role in metabolic
zonation is well established, and both deletion and stabilization
(via removal of its negative regulator APC) have been shown to
have a dramatic impact on lobular gene expression (Benha-
mouche et al., 2006; Burke et al., 2009). Chromatin immunopre-
cipitation sequencing (ChIP-seq) analysis has demonstrated that
b-catenin interacts with TCF4 to bind pericentral target genes,
including GS (encoded by Glul), thus demonstrating its direct
involvement in transcriptional regulation (Torre et al., 2011).
A recent study by Yang et al. further supported this concept by
demonstrating that conditional deletion of the Wnt receptors
Lrp5/6 in hepatocytes prevented the establishment of zonated
functions (Yang et al., 2014).
In the present study, we have shown that RSPO3 is specifically
expressed in the endothelium of the central, but not the portal
vein. Restricted expression commences prior to the establish-
ment of zonation and deletion of Rspo3 during late stages of
development interfered with the onset of zonation, thus confirm-
ing its essential role in establishing central hepatocyte identity.
Furthermore, Rspo3 deletion had no impact on Wnt expression
levels, demonstrating that the observed effects are due to Wnt/
b-catenin modulation rather than loss of Wnt ligands. Surpris-
ingly, some pericentral genes, such as Rdh9, displayed little
change upon Rspo3 deletion. This suggests that additional
mechanisms may contribute to regulate hepatic zonation, a hy-
pothesis recently put forward by Gebhardt and Matz-Soja (Geb-
hardt and Matz-Soja, 2014). Although dynamics of the zonated
genes during the perinatal period do not fully recapitulate that
of Wnt/b-catenin activity, qPCR analysis of the known b-catenin
targets Axin2, Oat, and Cyp2f2 confirms the strong impact of
Rspo3 deletion or activation of Rspo1 on Wnt/b-catenin-driven
transcriptional regulation.
The fact that loss of Rspo/Wnt/b-catenin signaling prevents
the activation of the pericentral differentiation suggests that por-
tal identity is the hepatocyte default state. Indeed, immediately
after birth, hepatocytes are periportal-like, and although Wnt/
b-catenin signaling is fully established by P10, the expression
of periportal markers such as E-cadherin (also considered as a
Wnt/b-catenin buffering system) is still retained in most hepato-
cytes, indicating that pericentral differentiation is a form of
specialization that allows the organism to cope with changes in
metabolic requirements.
By adulthood, metabolic zonation is firmly established, with
precise gene signatures distinguishing zone 1 and zone 3 hepa-
tocytes (Braeuning et al., 2006). The expression of GS and
Cyp7a1 (and Rdh9) closely follows that of the classical Wnt/
b-catenin targets Axin2 and Lgr5, thus further supporting the
concept that Wnt/b-catenin is the master regulator of liver zona-
tion. While this article was under revision, a paper by Wang et al.
reported thatWls, a gene essential for the sorting and secretion
of WNT proteins, is required within the endothelium to drive
b-catenin-induced cell renewal in central hepatocytes and
establish zonation (Wang et al., 2015). The observed phenotype
in our mutants is similar to but stronger than that observed by
endothelial deletion of Wls, demonstrating that Rspo3 plays a
crucial role in the regulation of Wnt/b-catenin signaling. The au-
thors further identified both Wnt2 and Wnt9b to be specifically
expressed in endothelial cells of the central vein (Wang et al.,ports 13, 1757–1764, December 1, 2015 ª2015 The Authors 1761
Figure 4. Ectopic Rspo1 Expression Induces Wnt/b-Catenin Signaling and Disrupts Liver Zonation
(A) Schematic representation of the genetic approach used to ectopically express Rspo1 in adulthood. Red arrowheads indicate loxP sites.
(B) Tamoxifen induction protocol used to induce Rspo1 expression in 8-week-old animals; livers were analyzed 2 days and 4 weeks after the final injection.
(C) qPCR analysis demonstrating Rspo1 induction and upregulation of the Wnt/b-catenin target genes Axin2 and LGR5. Wnt2 and Wnt9b expression was not
significantly affected by Rspo1 expression.
(D) In non-induced animals, GS expression is restricted to the hepatocytes surrounding the central vein (green), and ectopic expression of Rspo1 induces an
expansion of the GS+ domain. Portal tracts can be identified by bile ducts labeled by keratin 18 (Krt18) (red).
(E) qPCR analysis of additional Wnt/b-catenin target/zonated genes demonstrating upregulation of pericentral genes.
(F) Lack of E-cadherin immunostaining (green) in periportal hepatocytes demonstrating inhibition of periportal specification by RSPO1.
(G) Wnt/b-catenin-negative targets are strongly inhibited by Rspo1 upregulation.
cv, central vein. *p < 0.05; **0.05 < p < 0.001, ***p < 0.001 (Student’s t test). All scale bars represent 100 mm; error bars represent SD. See also Figures S3 and S4.2015), a finding that nicely confirms our own analysis. While a
specific deletion of Wnt2 and Wnt9b was not performed in this
study, it is likely that these two genes act together with Rspo3
to establish and maintain liver zonation.
Ectopic expression of Rspo1 throughout the liver acinus re-
sulted in the transformation of zone 2 hepatocytes to a pericen-
tral (zone 3) identity, as evidenced by the expansion of the
number of GS+ hepatocyte layers. Surprisingly, hepatocytes
close to the periportal system failed to express GS. This is in
contrast to mice carrying hepatocyte-specific deletion of APC,
a negative regulator of b-catenin signaling (Benhamouche
et al., 2006). APC levels are higher in periportal hepatocytes
(Benhamouche et al., 2006), and it is conceivable that b-catenin
activation by theRspo1 GOF allele was insufficient to completely
overcome the periportal APC activity. Of note, RSPO1 is less1762 Cell Reports 13, 1757–1764, December 1, 2015 ª2015 The Autefficient in supporting canonical b-catenin signaling when
compared to RSPO3 in cell culture systems (Kim et al., 2008).
Similarly, in AML12 cells, recombinant RSPO1 required ten times
higher concentrations than RSPO3 to induce similar levels of
Axin2.
An alternative explanation for the conversion of zone 2 hepa-
tocytes in RSPO1 overexpressing mice could be the expansion
of the recently identified Axin2+ progenitors (Wang et al., 2015)
that in combination with a permissive signaling environment
(high RSPO1 levels) would keep their identity while being dis-
placed along the central-portal axis. Although plausible, this hy-
pothesis has several pitfalls: (1) the expansion of theGS+domain
occurs in a reasonably short time frame when compared to the
time required for Axin2+ progenitors to replace the liver paren-
chyma (Wang et al., 2015); (2) while periportal hepatocytes failhors
to activate the Wnt/b-catenin target GS, they do respond to
Rspo1 upregulation, as evidenced by the loss of E-cadherin
expression; and (3) long-term follow up of the GOF animals
(9 months) failed to demonstrate an expansion of the GS+ hepa-
tocytes toward the portal vein. These observations suggest that
Rspo1 is inducing Wnt/b-catenin signaling, probably by ampli-
fying endogenous low-level Wnt signals that are absent from
periportal hepatocytes. Alternatively, a counteracting signal,
potentially released from the periportal triad, could interfere
with full-blown activation of b-catenin signaling in our GOF
model.
Rspondins are generally considered as facilitators of Wnt/
b-catenin signaling that exert their function by binding to LGR
receptors, most notably LGR5. LGR5 expression appears to
be very low in the liver, and we were unable to detect expres-
sion by ISH or antibody staining. Similarly, lineage-tracing ex-
periments using an LGR5-CreERT2 line did not mark central
hepatocytes (Huch et al., 2013). While expression appears to
be low, differential microarray analysis of central versus portal
hepatocytes identified LGR5 to be enriched in central hepato-
cytes, which is consistent with an RSPO3-LGR5-b-catenin
cascade in this compartment. Wang et al. recently performed
a lineage-tracing analysis of Axin2+ hepatocytes and demon-
strated that under physiological conditions, pericentral hepato-
cytes function as progenitors that replace the parenchyma
after 1 year. They further reported the existence of a pro-
genitor niche provided by endothelial Wnt2 and Wnt9b (Wang
et al., 2015). Interestingly, loss of Wnt ligands resulted in
decreased, but not abolished, proliferation of GS+ hepato-
cytes. However, the presence of GS in these pericentral
hepatocytes suggests that residual Wnt/b-catenin signaling
persisted in their model, which might account for the small dif-
ferences observed. Rspo3 knockout animals completely lack
GS expression, and it would be interesting to test whether pro-
genitor expansion would be more strongly affected in these
mutants. Unfortunately, ubiquitous deletion of Rspo3 causes
mortality 6 weeks following induction, thus preventing long-
term analysis.
In conclusion, our data imply that Rspondin activity is
required for Wnt-induced signaling and may therefore be
considered as a gatekeeper for the activation of the b-catenin
pathway in liver hepatocytes. The specific expression of
Rspo3, Wnt2, and Wnt9b in central veins is intriguing, as they
allow distinction of the endothelial compartments of the liver
at the molecular level. Although several hypotheses have
been put forward to explain the mechanisms responsible for
the onset and maintenance of metabolic zonation (Gebhardt
and Matz-Soja, 2014; Torre et al., 2010), the signal triggering
Wnt/b-catenin activation has remained elusive. Potential sig-
nals may include gradients of oxygen, nutrients, metabolites,
hormones, and cytokines along the lobules (Gebhardt and
Matz-Soja, 2014). Whatever the mechanism, it seems likely
that it will directly influence and induce the expression of
Rspo3 in the endothelial compartment of central veins.
The identification of RSPO3 as a key regulator of central iden-
tity may allow for the identification of such signaling path-
ways by monitoring the expression of RSPO3 under various
conditions.Cell ReEXPERIMENTAL PROCEDURES
Mice
All animal work was conducted according to national and international guide-
lines and has been approved by the local ethics committee (PEA NCE/2013-
88). The cCAG CreERT2; and Alb CreERT2 mouse lines were previously
described (Hayashi andMcMahon, 2002; Schuler et al., 2004). TheRspo3 con-
ditional allele has been generated at the Riken core facility and will be
described elsewhere (details on request). Rspo3 deletion was achieved by
intraperitoneal (i.p.) injection of 5 mg tamoxifen (Sigma-Aldrich) dissolved in
corn oil (Sigma-Aldrich), per 25 g body weight. Cre activation in the perinatal
period was obtained by a single tamoxifen administration into pregnant
females carrying E16.5 embryos. Cre activation in adult mice was obtained
by administrating tamoxifen for every other day for 1 week starting at 8 weeks
of age.
Immunofluorescence and Histological Analysis
For immunofluorescence experiments, tissues were fixed overnight in
ANTIGENFIX (DiaPath), progressively dehydrated, and paraffin embedded.
5-mm-thick sections were rehydrated, boiled in a pressure cooker for 2 min
with Antigen Unmasking Solution (Vector Laboratories), and blocked in a PBS
solution containing 10% normal donkey serum (Jackson ImmunoResearch)
and 1% BSA and 0.1% Triton X-100. All primary antibodies were applied over-
night at 4C at the concentration listed in Table S1. Secondary antibodies were
diluted 1:400 and applied at room temperature for 1 hr.
GS immunofluorescence after RNA in situ hybridization was performed
without antigen retrieval. For histological analysis, tissues were fixed overnight
in ANTIGENFIX (DiaPath), progressively dehydrated, and embedded in
paraffin-embedding media. 5-mm-thick sections were then stained with H&E.
RNA In Situ Hybridization
Tissues were fixed overnight in ANTIGENFIX (DiaPath), progressively dehy-
drated, and paraffin embedded. Then, 7-mm-thick sections were hybridized
with Rspo3 probe (details on request) according to previously described pro-
tocols (Comai et al., 2010).
Cell Culture
The AML12 cell line was maintained in a 1:1 mixture of DMEM and Ham’s F12
medium with 0.005 mg/ml insulin, 0.005 mg/ml transferrin, 5 ng/ml selenium,
40ng/ml dexamethasone and 10% fetal bovine serum, in a humidified atmo-
sphere (5%CO2) at 37
C. All culture reagents were purchased from Invitrogen.
All stimulations were performed according to the following procedure: cells
were propagated in standard culturemedium and serum starved for 12 hr, after
which recombinant mouse RSPO1 or RSPO3 proteins (R&D Systems) were
added in fresh serum-free medium. Cells were stimulated for 24 hr, and RNA
was extracted.
Liver Cell Isolation and Flow Cytometry
Livers were collected from 8-week-old animals, and nonparenchymal cells
were isolated following the protocol described by Rountree et al. (Rountree
et al., 2011). Briefly, the tissue was digested in PBS containing 5 mg collage-
nase type I (Worthington), 5 mg pronase (Roche) and 1mg DNase (Roche) for
30 min at 37C. The liver was dissociated and passed through a 70-mm filter.
Hepatocytes were separated from nonparenchymal cells by serial low-speed
centrifugations (50 3 g for 1 min). The supernatant was then stained with
CD31-647 (eBioscience). Cells were analyzed with a FACS ARIA II (BD).
qRT-PCR
RNA was extracted from AML12 cells or P10 or adult livers using TRIzol re-
agent (Invitrogen), following the manufacturer’s instructions. Reverse tran-
scription was performed using M-MLV reverse transcriptase (Invitrogen) in
combination with polydT primers. The cDNA obtained was then used as a tem-
plate for qPCR carried out using the SYBR Green Master Kit (Roche) and a
Light Cycler 480 (Roche). Expression levels were normalized for GAPDH.
Primers (see Table S2 for primer sequences) were designed on the Roche Uni-
versal Probe Library website.ports 13, 1757–1764, December 1, 2015 ª2015 The Authors 1763
Statistical Analysis
Statistical analysis was performed according to the Student’s t test. Error es-
timates are expressed as SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
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